Dr Jane Wolstenholme
|Tel||+44 (0)1865 289269|
BA(Hons) (London), MSc (York), PhD (Nottingham)
Senior Health Economist, HERC
Jane Wolstenholme has 20 years of experience of conducting economic evaluations for health policy makers and exploring methodological issues relating to the design and analysis of economic evaluations. She has been a health economist at HERC since 1998.
Her main interests include designing and conducting economic evaluations alongside trials and cost-effectiveness models. She is principal investigator and co-applicant on a wide variety of funded research projects, across a number of disease areas and health-care technologies, including cancer, chronic kidney disease, obesity, mental health, point of care diagnostics. She is a health economics advisor for the RDS South Central and for the NIHR Diagnostics Evidence Co-Operative, Oxford. She supervises MSc and DPhil students. Jane has published widely and is co-author of a major OUP text book ‘Applied Methods of Cost-effectiveness Analysis in Health Care’.
Non-contact infrared thermometers for measuring temperature in children: primary care diagnostic technology update.
Wang K. et al, (2014), Br J Gen Pract, 64, e681 - e683
Oral corticosteroid use for clinical and cost-effective symptom relief of sore throat: study protocol for a randomized controlled trial.
Cook J. et al, (2014), Trials, 15
Economic evaluations in bipolar disorder: a systematic review and critical appraisal.
Abdul Pari AA. et al, (2014), Bipolar Disord, 16, 557 - 582
Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies.
Leal J. et al, (2014), Int J Urol, 21, 786 - 792
PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial.
Watson E. et al, (2014), BMJ Open, 4